Blai Coll
Vermogen: 600 072 $ op 31-05-2026
Vermogen: 600 072 $ op 31-05-2026
Dr. Blai Coll is a Chief Medical Officer at Structure Therapeutics, Inc. Dr. Coll was previously employed as a Medical Director by AbbVie, Inc. He received his doctorate degree from Autonomous University of Barcelona and a doctorate degree from Universitat Rovira i Virgili.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 45.765 ( 0,03% ) | 600 072 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 18-09-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBVIE INC. | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Autonomous University of Barcelona
Autonomous University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universitat Rovira i Virgili
Universitat Rovira i Virgili Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau